GL1X · GenesisL1 explorer

Research workbench

Inhibitor complex with thrombin activatable fibrinolysis inhibitor (tafia)

Analyse Inhibitor complex with thrombin activatable fibrinolysis inhibitor (tafia) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7NEE
Type
protein
Length
400 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Carboxypeptidase B2
EC
3.4.17.20
UniProt
Q96IY4
Ligands
U9B, ZN
Pockets
2 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACarboxypeptidase B2 (EC 3.4.17.20)protein40038% helix, 18% strandQ96IY4

Ligands and binding sites

  • U9B · (1R,3S)-3-(4-ammoniobutyl)-1-benzyl-1,4-azaphosphinan-1-ium-3-carboxylate 4,4-dioxide · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14010.730.8440U9B
21230.400.7521empty

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 7NEE · Inhibitor Complex with Thrombin Activatable Fibrinolysis inhibitor (TAFIa) · the same entry in another collection · chain A against A, TM-score 1.00
  • Q96IY4 · AlphaFold monomer V2.0 prediction for carboxypeptidase B2 (Q96IY4) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.